Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analytical validation and implementation of a pan cancer next-generation sequencing panel, CANSeqTMKids for molecular profiling of childhood malignancies. | Front Genet | 2023 | 36845394 | PubTator, text mining | PubMed |
| Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. | Int J Mol Sci | 2023 | 36835134 | PubTator, text mining | PubMed |
| Enhancing Skin Cancer Immunotheranostics and Precision Medicine through Functionalized Nanomodulators and Nanosensors: Recent Development and Prospects. | Int J Mol Sci | 2023 | 36834917 | PubTator, text mining | PubMed |
| Metastatic Progression of Human Melanoma. | Cancers (Basel) | 2023 | 36831566 | PubTator, text mining | PubMed |
| Gβγ signaling regulates microtubule-dependent control of Golgi integrity. | Cell Signal | 2023 | 36805843 | PubTator, text mining | PubMed |
| Long Noncoding RNA SAMMSON Promotes Melanoma Progression by Inhibiting FOXA2 Expression. | Stem Cells Int | 2023 | 36798674 | PubTator, text mining | PubMed |
| Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone. | Proc Natl Acad Sci U S A | 2023 | 36795755 | PubTator, text mining | PubMed |
| Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data. | Front Immunol | 2023 | 36793711 | PubTator, text mining | PubMed |
| Catalytic site mutations confer multiple states of G protein activation. | Sci Signal | 2023 | 36787384 | PubTator, text mining | PubMed |
| Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations. | Drug Des Devel Ther | 2023 | 36785760 | PubTator, text mining | PubMed |
| CD8/PD-L1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma. | PLoS One | 2023 | 36780540 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of atypical parathyroid adenoma compared with parathyroid carcinoma and benign lesions in a Chinese cohort. | Front Endocrinol (Lausanne) | 2023 | 36777354 | PubTator, text mining | PubMed |
| Extraskeletal Ewing's sarcoma of the mediastinum: Case report. | Front Oncol | 2023 | 36776337 | PubTator, text mining | PubMed |
| Repetitive Bleomycin-Based Electrochemotherapy Improves Antitumor Effectiveness in 3D Tumor Models of Conjunctival Melanoma. | J Clin Med | 2023 | 36769736 | PubTator, text mining | PubMed |
| Detection of Circulating Tumor Cell-Related Markers in Gynecologic Cancer Using Microfluidic Devices: A Pilot Study. | Int J Mol Sci | 2023 | 36768623 | PubTator, text mining | PubMed |
| Alterations in Natural Killer Cells in Colorectal Cancer Patients with Stroma AReactive Invasion Front Areas (SARIFA). | Cancers (Basel) | 2023 | 36765951 | PubTator, text mining | PubMed |
| Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma. | Cancers (Basel) | 2023 | 36765842 | PubTator, text mining | PubMed |
| Genetics and RNA Regulation of Uveal Melanoma. | Cancers (Basel) | 2023 | 36765733 | PubTator, text mining | PubMed |
| An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. | Cancers (Basel) | 2023 | 36765694 | PubTator, text mining | PubMed |
| The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. | Br J Cancer | 2023 | 36759723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=23